US EditionPsilocybin Therapy Offers "Paradigm-Changing Alternative" to Conventional Treatment for Depression, Clinical Trials Show
UNITED STATES, JUN 16 – Over half of cancer patients experienced sustained remission of depression symptoms two years after a single psilocybin dose combined with psychotherapy, indicating durable therapeutic effects.
- A single dose of psilocybin has been shown to provide lasting relief from depression and anxiety in cancer patients suffering from major depressive disorder, according to results from a clinical trial.
- Two years post-treatment, 53.6% of patients demonstrated significant depression reduction, with 50% achieving sustained remission.
- At the two-year follow-up, psilocybin reduced anxiety in 42.9% of patients.
- These findings suggest that psilocybin-assisted therapy may serve as a potent and safe alternative to conventional antidepressants for cancer patients' emotional challenges.
47 Articles
47 Articles
Can Ketamine Help Treat Depression?
In a new study, scientists watched something strange happen inside the brain after a single dose of ketamine: the usual cognitive chain of command seemed to collapse. Normally, sensory info comes in through lower-level brain networks, then gets filtered up to higher-level regions that run things like decision-making, introspection, and memory. But after ketamine, those boundaries got fuzzy. The brain’s high-level networks loosened control, and c…
Marijuana Moment
newsbudz.comHigh Doses Of LSD Lead To ‘Greater Reductions In Depression’ Compared To Low Doses Of The Psychedelic, New Study Finds
Taking a high dose of LSD, coupled with assisted therapy, led to “greater reductions in depression” among patients compared to those who received a low dose of the psychedelic, according to a new study. Researchers at the University of Basel in Switzerland investigated the therapeutic potential of LSD for people with moderate-to-severe major depressive disorder, and they found the substance showed “promise” as a “novel approach” to treating the …
Psilocybin for Depressed Cancer Patients; GLP-1s With Clozapine; Global OCD Trip
(MedPage Today) -- A single dose of psilocybin combined with psychological support reduced anxiety and depression for 2 years in people with cancer and major depressive disorder in a phase II trial. (Cancer) The American Psychiatric Association...
For cancer patients with depression, psilocybin may provide lasting relief
A single dose of psilocybin provides long-term reductions in anxiety and depression in cancer patients, a new study shows. Cancer patients can experience depression so severe that it affects their ability to go through treatment. Psilocybin, a chemical in some mushrooms that causes psychedelic effects, has been linked to reductions in depression.
Coverage Details
Bias Distribution
- 41% of the sources lean Left, 41% of the sources are Center
To view factuality data please Upgrade to Premium
